Congressional debate over lowering drug prices has shifted to the U.S. Senate.

After Successful House Vote, Attention Turns to Senate on Major Drug Pricing Bill

Congressional debate over lowering drug prices has shifted to the U.S. Senate following House passage of the $1.75 trillion Build Back Better social spending bill on Friday.

Congress has been on break this week for the Thanksgiving holiday. It returns to work on Monday. Before the Senate can take up the bill, the Senate Parliamentarian must first decide whether its provisions align with the chambers’ rules. In addition, individual senators are expected to insist on making major changes to the bill. The House and Senate both then would have to sign off on final language before the bill could go to President Biden for his signature.

Congressional debate over lowering drug prices has shifted to the U.S. Senate following House passage of the $1.75 trillion Build Back Better social spending bill on Friday.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report